DDD Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729K Buy
2,984
+1,652
+124% +$385K 0.05% 81
2025
Q4
$276K Buy
1,332
+145
+12% +$28.7K 0.02% 111
2025
Q3
$220K Sell
1,187
-129,254
-99% -$22.1M 0.01% 121
2025
Q2
$19.9M Sell
130,441
-14,833
-10% -$2.28M 2.14% 19
2025
Q1
$24.1M Buy
145,274
+48,774
+51% +$7.63M 2.93% 8
2024
Q4
$14M Sell
96,500
-28,809
-23% -$4.46M 1.72% 26
2024
Q3
$20.3M Buy
125,309
+643
+0.5% +$102K 2.21% 24
2024
Q2
$18.2M Buy
124,666
+396
+0.3% +$58.9K 2.11% 20
2024
Q1
$19.7M Buy
124,270
+9,496
+8% +$1.51M 2.4% 21
2023
Q4
$18M Buy
114,774
+13,091
+13% +$2.01M 2.42% 17
2023
Q3
$15.9M Sell
101,683
-2,012
-2% -$332K 2.29% 19
2023
Q2
$17.2M Buy
103,695
+884
+0.9% +$143K 2.38% 19
2023
Q1
$15.9M Buy
102,811
+1,050
+1% +$170K 2.48% 19
2022
Q4
$18M Buy
101,761
+1,581
+2% +$273K 2.88% 13
2022
Q3
$16.4M Sell
100,180
-11,388
-10% -$1.93M 2.97% 7
2022
Q2
$19.8M Buy
111,568
+1,195
+1% +$213K 3.43% 12
2022
Q1
$19.6M Buy
110,373
+2,453
+2% +$417K 2.68% 15
2021
Q4
$18.5M Buy
107,920
+1,666
+2% +$273K 2.53% 14
2021
Q3
$17.2M Buy
106,254
+1,078
+1% +$184K 2.57% 16
2021
Q2
$17.3M Buy
105,176
+2,115
+2% +$350K 2.63% 16
2021
Q1
$16.9M Buy
103,061
+2,517
+3% +$407K 2.89% 13
2020
Q4
$15.8M Buy
100,544
+4,945
+5% +$730K 3.12% 12
2020
Q3
$14.2M Buy
95,599
+19,107
+25% +$2.83M 3.7% 9
2020
Q2
$10.8M Buy
76,492
+6,486
+9% +$945K 3.08% 18
2020
Q1
$9.18M Buy
70,006
+2,754
+4% +$391K 3.19% 12
2019
Q4
$9.81M Sell
67,252
-934
-1% -$127K 2.71% 19
2019
Q3
$8.82M Sell
68,186
-492
-0.7% -$64.8K 2.71% 19
2019
Q2
$9.56M Buy
68,678
+78
+0.1% +$10.8K 3.06% 13
2019
Q1
$9.59M Buy
68,600
+1,086
+2% +$145K 3.3% 15
2018
Q4
$8.71M Sell
67,514
-81
-0.1% -$11.3K 3.25% 14
2018
Q3
$9.34M Buy
67,595
+350
+0.5% +$46.5K 3.32% 13
2018
Q2
$8.16M Buy
67,245
+1,261
+2% +$157K 3.32% 15
2018
Q1
$8.46M Buy
65,984
+1,381
+2% +$187K 3.41% 11
2017
Q4
$9.03M Buy
+64,603
New +$9M 3.51% 10

Other funds holding JNJ

DDD Partners's JNJ Position: Q1 2026 in Review

DDD Partners increased its Johnson & Johnson (JNJ) stake by 124% in Q1 2026, buying an estimated $385K and bringing the position to 2,984 shares worth $729K. The position accounts for 0.05% of the portfolio, ranked #81.

DDD Partners first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $24.1M in Q1 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • DDD Partners held 2,984 shares of Johnson & Johnson worth $729K as of Q1 2026.
  • DDD Partners bought 1,652 Johnson & Johnson shares in Q1 2026, an estimated $385K.
  • Johnson & Johnson made up 0.05% of DDD Partners's portfolio in Q1 2026, its #81 holding.
  • DDD Partners first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • DDD Partners's Johnson & Johnson position peaked at $24.1M in Q1 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on DDD Partners's 13F filing for Q1 2026, filed 28 Apr 2026.